BDH Industries Quarterly Results for Trading Insights
In 2026, BDH Industries (BDH) reported revenue ₹87 Cr and net profit ₹10 Cr. Also explore BDH share price data to track price trends across different timeframes.
BDH Quarterly Results — Revenue, Profit & EPS Highlights
BDH Industries latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with BDH Industries valuation methods to assess whether the stock is under or overvalued.
- Revenue of ₹68 Cr in March 2025 (+0.0% vs March 2025, -21.8% vs March 2024)
- Net Profit of ₹9 Cr in March 2025 (+0.0% vs March 2025, -10.0% vs March 2024)
- EBITDA of ₹13 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 17.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹16.11 in March 2025 (+0.0% vs March 2025)
BDH Industries Quarterly Results — Revenue, EBITDA, Net Profit & EPS
BDH quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 87 | 68 | 87 | 75 | 70 | 27.9% | - |
| Net Profit (₹ Cr) | 10 | 9 | 10 | 8 | 7 | - | - |
| EBITDA (₹ Cr) | 15 | 13 | 14 | 12 | 10 | - | - |
| EPS (₹) | 18.10 | 16.11 | 17.14 | 14.25 | 12.55 | - | - |
| Operating Margin (%) | 15.0% | 17.0% | 14.0% | 15.0% | 13.0% | - | - |
BDH Share Price Trend — 1-Year Movement Across Quarterly Results
BDH Industries 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit BDH Industries share price chart.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
BDH vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
BDH Industries latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹450,643.09 Cr | 1844.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 141.9 |
|
Divis Laboratories
Sept 2025 |
₹179,470.03 Cr | 6887.0 | 2,860 | 689 | +7.1% | - | 24.1% | 265.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,702.77 Cr | 4486.2 | 3,219 | 591 | +11.3% | - | 18.4% | 255.8 |
|
Cipla
Mar 2026 |
₹115,205.68 Cr | 1399.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 203.7 |
|
Dr Reddys Laborator…
Mar 2026 |
₹111,107.68 Cr | 1307.2 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 493.3 |
All amounts in ₹ Crores